#AimiGPT | Panel 3: The Ethics, Equity, and Regulation around LLMs/ChatGPT

“Can ChatGPT diagnose me?” How Large Language Models Will Transform Clinical Care took place on April 27, 2023.

In what ways might these new tools affect diagnostic disparities in the US? How might the pre-existing biases in the training data potentially perpetuate disparities? How might we mitigate these effects? How should these tools be classified from a regulatory perspective (e.g., as a medical device or as a general wellness tool)? And how might that influence their safety, efficacy and usefulness? Other ethical considerations (e.g., patient consent, data privacy, risk of security / adversarial attacks)

PANEL 3:
Justin Norden - Partner, GSR Ventures (Moderator)
Glenn Cohen - Deputy Dean and James A. Attwood and Leslie Williams Professor of Law, Harvard Law School; Faculty Director, Petrie-Flom Center for Health Law Policy, Biotechnology & Bioethics, Harvard University
Lisa Lehmann - Brigham and Women's Hospital, Department of Medicine and Harvard Medical School
Yauheni Solad - Chief Medical Information Officer, UC Davis Health
Troy Tazbaz - Director of Digital Health Center of Excellence, FDA

This event is co-hosted by the Stanford Center for Artificial Intelligence in Medicine and Imaging (AIMI) and Stanford Institute for Human-Centered Artificial Intelligence (HAI) and co-sponsored by the Gordon and Betty Moore Foundation and GSR Ventures.

Learn about upcoming events here: aimi.stanford.edu/events